Article: Is there an association between ABO blood group and overall survival in patients with esophageal squamous cell carcinoma?

Background: The relationship between ABO blood group and clinical characteristics had been studied in several cancers. However, its role in esophageal cancer (EC) is unclear. The aim of this study was to determine whether ABO blood group is associated with overall survival in patients with esophageal squamous cell carcinoma (ESCC).

Methods: From 2005 to 2008, a retrospective analysis of 496 consecutive patients with ESCC was conducted. The relationship between ABO blood group and clinicopathologic features of ESCC was analyzed. Prognostic factors for overall survival of ESCC were also analyzed.

Results: The 5-year overall survival of ESCC patients with blood group A, B, AB and O were 47.8%, 44.1%, 43.2%, and 38.4%, respectively (P = 0.165). However, patients with blood group non-O have a better 5-year overall survival than patients with blood group O (45.7% vs. 38.4%; P = 0.043). Multivariate analyses showed ABO blood group (O vs. non-O; P = 0.034) is an independent prognostic factors.

Conclusions: ABO blood group is associated with overall survival in patients with ESCC. We concluded that patients with blood group O have a significantly worse overall survival than non-O blood groups.

Citing Articles

ABO Blood Type and Clinical Characteristics Among Japanese Patients With Ulcerative Colitis.

Yagi S, Furukawa S, Tange K, Ninomiya T, Suzuki S, Ohashi K Cureus. 2024; 16(5):e59787.

PMID: 38846206 PMC: 11154843. DOI: 10.7759/cureus.59787.

Blood Group Type Association with Head and Neck Cancer.

Alexandra G, Alexandru M, Stefan C, Petruta-Maria D, Gabriel B, Dragos-Eugen G Hematol Rep. 2022; 14(1):24-30.

PMID: 35323176 PMC: 8954807. DOI: 10.3390/hematolrep14010005.

The association between ABO blood group distribution and peptic ulcer disease: a cross-sectional study from Ethiopia.

Teshome Y, Mekonen W, Birhanu Y, Sisay T J Blood Med. 2019; 10:193-197.

PMID: 31308778 PMC: 6613600. DOI: 10.2147/JBM.S209416.

ABO blood groups as a prognostic factor for recurrence in ovarian and vulvar cancer.

Sartorius C, Schoetzau A, Kettelhack H, Fink D, Hacker N, Fedier A PLoS One. 2018; 13(3):e0195213.

PMID: 29596526 PMC: 5875852. DOI: 10.1371/journal.pone.0195213.

The prognostic value of tumor length to resectable esophageal squamous cell carcinoma: a retrospective study.

Zhang X, Wang Y, Li C, Helmersson J, Jiang Y, Ma G PeerJ. 2017; 5:e2943.

PMID: 28168111 PMC: 5289103. DOI: 10.7717/peerj.2943.

References

1.

Wolpin B, Chan A, Hartge P, Chanock S, Kraft P, Hunter D . ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst. 2009; 101(6):424-31. PMC: 2657095. DOI: 10.1093/jnci/djp020. View

2.

Su M, Lu S, Tian D, Zhao H, Li X, Li D . Relationship between ABO blood groups and carcinoma of esophagus and cardia in Chaoshan inhabitants of China. World J Gastroenterol. 2002; 7(5):657-61. PMC: 4695569. DOI: 10.3748/wjg.v7.i5.657. View

3.

Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D . Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2011; 127(12):2893-917. DOI: 10.1002/ijc.25516. View

4.

Urun Y, Ozdemir N, Utkan G, Akbulut H, Savas B, Oksuzoglu B . ABO and Rh blood groups and risk of colorectal adenocarcinoma. Asian Pac J Cancer Prev. 2013; 13(12):6097-100. DOI: 10.7314/apjcp.2012.13.12.6097. View

5.

Engin H, Bilir C, Ustun H, Gokmen A . ABO blood group and risk of pancreatic cancer in a Turkish population in Western Blacksea region. Asian Pac J Cancer Prev. 2012; 13(1):131-3. View

Is There an Association Between ABO Blood Group and Overall Survival in Patients with Esophageal Squamous Cell Carcinoma?